Cutera® and Restimulate Health™ Announce Strategic Partnership to Advance Rehabilitation with truFlex Technology
09:01 ET Revance Announces Appointment of Steve Kreider as EVP, Chief Revenue Officer - Aesthetics and Therapeutics
08:01 ET Cutera® Announces New FDA Clearances for truFlex® to Support Rehabilitation, Recovery and Muscle Wellness
Cutera Announces Voluntarily Delisting from Nasdaq | CUTR Stock News
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success | CUTR Stock News